the invention realtes to improved liquid phase processes for the preparation of the 21 residue protein component , 4 - lys , of the pulmonary surfactant kl - 4 . these process are amenable to large scale synthesis and one process employs a method of saponifying an ester which reduces the inherent racemization of the α - carbon .